JOHN BRIDGES: Open Payments
NPI 1891301701 · CORDELE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$718 in 42 payments from 14 companies in 2025. Trend: 2023 $237 · 2024 $735 · 2025 $718
Food & beverage: $718
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $143 |
| Lilly USA, LLC | 5 | $96 |
| AstraZeneca Pharmaceuticals LP | 5 | $89 |
| Amgen Inc. | 4 | $62 |
| ABBVIE INC. | 3 | $56 |
| GlaxoSmithKline, LLC. | 3 | $48 |
| PFIZER INC. | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 3 | $46 |
| Phathom Pharmaceuticals, Inc. | 4 | $31 |
| Astellas Pharma US Inc | 1 | $29 |
Products named: Ozempic, TRELEGY ELLIPTA, REXULTI, OTEZLA, FARXIGA, Wegovy, MOUNJARO, PREVNAR 20.
Industry payments across GA — which companies pay providers there.
